Immunity in the Connective Tissue Diseases

References

• Williams A F, Barclay A N. The immunoglobulin superfamily domains for cell surface recognition. Annu Rev Immunol 1988; 6: 381–405
   PubMed Web of Science ®Google Scholar
• Hunkapillar T, Hood L. Diversity of the immunoglobulin gene superfamily. Adv Immunol 1989; 44: 1–63
   PubMed Web of Science ®Google Scholar
• Williams A F. A year in the life of the immunoglobulin superfamily. Immunol Today 1987; 8: 298–303
   PubMedGoogle Scholar
• Williams R C, Jr, Malone C C, Tsuchiya N. Rheumatoid factors from patients with rheumatoid arthritis react with β2-micro-globulin. J Immunol 1992; 149: 1104–13
   PubMed Web of Science ®Google Scholar
• Tussey L G, Frelinger J A. Detergent enhances binding of a secreted HLA-A2 molecule to solid phase peptides. Human Immunol 1991; 32: 183–93
   PubMedGoogle Scholar
• Cohen N, Crawford J S, Hiraki D, Grumet F C. Secretion of genetically engineered human/mouse Class I antigens. Hum. Immunology 1989; 25: 207–22
   PubMedGoogle Scholar
• Williams R C, Jr, Malone C C, Casali P. Antigen-induced aggregation of Gm(α)(-), Gm(γ)(-) IgG results in exposure of determinants recognized by heteroclitic polyclonal and monoclonal anti-Gm(α) and Gm(γ) human rheumatoid factors. Relevance to the in vivo induction of high affinity anti-IgG autoantibodies. J Immunol 1992; 149: 1817–24
   PubMedGoogle Scholar
• Williams R C, Jr, Malone C C, Solomon A. Conformational dependency of human IgG heavy-chain associated Gm allotypes. Molecular Immunology 1993; 30: 341–51
   PubMedGoogle Scholar
• Williams R C, Jr, Malone C C, Harley J B. Rheumatoid factors from patients with rheumatoid arthritis react with tryptophane 60 and 95, lysine 58 and argjnine 97 on human β2-microglobu-lin. Arthritis & Rheum 1993; 36: 916–26
   PubMedGoogle Scholar
• Williams R C, Jr, Nissen M H, Malone C C. Rheumatoid factors from patients with rheumatoid arthritis react with Des-Lys58-β2m, modified β2-microglobulin. Clin & Exp Immunol 1993; 92: 419–24
   PubMedGoogle Scholar
• Williams R C, Jr, Kievit E, Tsuchiya N, Malone C C, Hutt-Fletcher L. Differential mapping of Fcg-binding and monoclonal-antibody-reactive epitopes on gE, the Fcγ-binding glycoprotein of herpes simplex virus type 1. J Immunol 1992; 149: 2415–27
   PubMed Web of Science ®Google Scholar
• Williams R C, Jr, Malone C C. Antigenic epitopes on p2m reacting with monoclonal antibodies. J Lab & Clin Med 1993; 121: 805–20
   PubMedGoogle Scholar
• James J A, Harley J B. Linear epitope mapping an Sm B/B1 polypeptide. J Immunol 1992; 148: 2074–9
   PubMedGoogle Scholar
• Merrifield R B. Solid phase peptide synthesis. Adv Enzymol 1969; 32: 221–96
   PubMedGoogle Scholar
• Van der Woude F J, Rasmussen N, Lobatto S, Wiik A, Permin H, Van Es L A, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker for disease activity in Wegener's granulomatosis. Lancet 1985; 1: 425–9
   PubMed Web of Science ®Google Scholar
• Ludemann G, Gross W L. Autoantibodies against cytoplasmic structures of neutrophil granulocytes in Wegener's granulomatosis. Clin Exp Immunol 1987; 69: 350–7
   PubMedGoogle Scholar
• Williams R C, Jr, Staud R, Malone C C, Payabyab J, Byres L, Underwood D. Epitopes on proteinase-3 recognized by antibodies from patients with Wegener's granulomatosis. J Immunol 1994; 152: 4722–37
   PubMed Web of Science ®Google Scholar
• Franklin E C, Holman H R, Muller-Eberhard H J, Kunkel H G. An unusual protein component of high molecular weight in the serum of patients with rheumatoid arthritis. J Exp Med 1957; 105: 425–38
   PubMed Web of Science ®Google Scholar
• Kunkel H G, Franklin E C, Muller-Eberhard H J. Studies on the isolation and characterization of the ‘rheumatoid factor’. J Clin Invest 1959; 38: 424–34
   PubMed Web of Science ®Google Scholar
• Kunkel H G, Muller-Eberhard H J, Fudenberg H H, Tomasi T B. Gamma globulin complexes in rheumatoid arthritis and certain other conditions. J Clin Invest 1961; 40: 117–29
   PubMed Web of Science ®Google Scholar
• Grubb R, Laurell A B. Hereditary serological human serum groups. Acta Pathol Microbiol Scand 1956; 39: 390–8
   PubMedGoogle Scholar
• Grubb R. The genetic markers of human immunoglobulins. Springer-Verlag, New York 1970; 1–152
   Google Scholar
• Fudenberg H H, Kunkel H G. Specificity of the reaction between rheumatoid factors and gamma globulin. J Exp Med 1961; 114: 257–78
   PubMedGoogle Scholar
• Grubb R, Kronvall G, Martensson L. Some aspects of the relations between rheumatoid arthritis, antigammaglobulin factors and the polymorphism of human gammaglobulin. Ann NY Acad Sci 1965; 124: 865–72
   PubMed Web of Science ®Google Scholar
• Stage S E, Mannik M. Rheumatoid factors in rheumatoid arthritis. Bull Rheumatic Diseases 1972; 23: 720–5
   PubMedGoogle Scholar
• Williams R C, Jr. Rheumatoid factors. Human Pathol 1983; 14: 386–91
   PubMedGoogle Scholar
• Geysen H M, Rodda S J, Mason T J, Tribbick G, Schoots P G. Strategies for epitope analysis using peptide synthesis. J Immunol Methods 1987; 102: 259–74
   PubMed Web of Science ®Google Scholar
• Getzoff E D, Geysen H M, Rodda S J, Alexander H, Tainer J A, Lerner R A. Mechanisms of antibody binding to a protein. Science 1987; 235: 1191–6
   PubMed Web of Science ®Google Scholar
• Novotny J, Handschumacher M, Haber E. Location of antigenic epitopes on antibody molecules. J Mol Biol 1986; 189: 715–21
   PubMed Web of Science ®Google Scholar
• Peterson C, Malone C C, Williams R C, Jr. Rheumatoid factor-reactive sites on CH3 established by overlapping 7-mer peptide epitope analysis. Clin Res 1993; 41: 187A
   Google Scholar
• Williams R C, Jr, Malone C C. Human IgM rheumatoid factors react with Class I HLA molecules. Arthritis Rheum 1993; 36: D203, (S265)
   Google Scholar
• Henshaw T J, Malone C C, Gabay J E, Williams R C, Jr. Elevations of neutrophil proteinase 3 in serum of patients with Wegener's granulomatosis and polyarteritis nodosa. Arthritis Rheumatism 1994; 37: 104–12
   PubMedGoogle Scholar
• Mongan E S, Cass R M, Jacox R F, Vaughan J H. A study of the relation of seronegative and seropositive rheumatoid arthritis to each other and to necrotizing vasculitis. Amer J Med 1969; 47: 23–35
   PubMed Web of Science ®Google Scholar
• Epstein W V, Engleman E P. The relation of rheumatoid factor content of serum to clinical neurovascular manifestations of rheumatoid arthritis. Arthritis Rheum 1959; 2: 250–8
   PubMedGoogle Scholar
• Aranson J A, Jonsson T H, Brekkan A, Sigurjonsson K, Valdimarsson H. Relation between bone erosions and rheumatoid factor isotypes. Ann Rheum Disease 1987; 46: 380–4
   PubMedGoogle Scholar
• Van de Wiel B A, Dolman K M, Van der Meer-Gerritsen C H, Hack C E, Von dem Borne Kr A EG, Goldschmeding R. Interference of Wegener's granulomatosis autoantibodies with neutrophil proteinase 3 activity. Clin Exp Immunol 1992; 90: 409–14
   PubMedGoogle Scholar
• Dolman K M, Stegeman C A, Van de Wiel B A, Hack C E, Von dem Borne Kr A EG, Kallenberg C GM, Goldschmeding R. Relevance of classic anti-neutrophil cytoplasmic autoantibody (cANCA)-mediated inhibition of proteinase 3-al-antitrypsin complexation to disease activity in Wegener's granulomatosis. Clin Exp Immunol 1993; 93: 405–10
   PubMed Web of Science ®Google Scholar
• Pall A A, Varagunam M, Adu D, Smith N, Richards N T, Taylor C M, Michael J. Anti-idiotypic activity against anti-myeloperoxidase antibodies in pooled human immunoglobulin. Clin Exp Immunol 1994; 95: 257–62
   PubMedGoogle Scholar